Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study
Sign Up to like & getrecommendations! Published in 2024 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2024.2343084
Abstract: ABSTRACT Purposes This study investigated the feasibility of adalimumab (ADA) dose reduction and withdrawal strategy in children with stable pediatric non-infectious uveitis (PNIU). Methods This open-label prospective pilot trial recruited 18 stable PNIU patients (33… read more here.
Keywords: dose reduction; uveitis; ada; reduction withdrawal ... See more keywords